The algorithm, which has been used by more than 5,000 Mercy patients, predicts when cancer patients could be at risk of hospital admission due to chemotherapy side effects. Through the Chen Chemotherapy Model, patients can text their symptoms to Mercy, and an algorithm will help determine their risk of hospitalization.
The program was first developed through an AI-focused partnership with Microsoft.
“Historically, we have not known which patients are having a problem until they presented to the ER or called the office, which was typically late in the day when we had limited options available,” Jay Carlson, DO, Mercy Cancer Care Performance Acceleration medical director, told the Journal. “The Chen Chemotherapy Model and smart texting allows us to proactively manage these patients and identify when they are having problems earlier in the journey.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
